Fierce Biotech Mix Logo.png Fierce Biotech Mix Logo.png
Webinar

Streamlining the Alzheimer's Disease Journey

Available on-demand
60 Minutes

Join Eisai and expert partners from the Davos Alzheimer’s Collaborative and Norton Neuroscience Institute for an in-depth discussion on streamlining the Alzheimer’s disease patient journey. This webinar will explore the innovative Brain Health Navigator (BHN) Program, a model designed to improve early detection, streamline diagnosis, and support patients and caregivers through cognitive decline.

Attendees will learn:

  • How diverse collaborators partnered to address unmet needs in Alzheimer's disease care, drawing inspiration from oncology and diabetes.
  • How Brain Health Navigators guide patients and families through early cognitive decline including outcomes from a pilot program.
  • Best practices for implementing scalable, sustainable brain health navigation models and accelerating adoption of innovations in health care systems.

Gain actionable insights to improve patient access, care coordination, and system readiness in Alzheimer’s disease.

Speakers

Eisai-HS-Greg.png

Gregory E. Cooper, M.D., Ph.D.

Dr. Greg Cooper earned his M.D./Ph.D. from the University of Kentucky, completing his neurology residency and behavioral neurology fellowship at the University of Iowa. Dr. Cooper spearheads the Brain Health Navigator program at Norton, a Davos Alzheimer’s Collaborative program aimed at creating a worldwide model to prevent, diagnose and treat Alzheimer’s disease. Dr. Cooper serves as a principal investigator on numerous clinical trials.

Eisai-HS-Phyllis.png

Phyllis Barkman Ferrell, DrPH, MBA

Phyllis Ferrell retired after three decades as a life sciences executive, most recently as the leader for the late-stage Alzheimer’s disease assets in Lilly’s pipeline. In 2020, Phyllis was placed as an executive-on-loan to the World Economic Forum where she serves as a senior advisor of the Davos Alzheimer’s Collaborative Healthcare System Preparedness program. Phyllis has a BA in Economics from DePauw University, an MBA from Stanford University, and a doctorate in Global Public Health Leadership from Indiana University.

Eisai-HS-Sarah.png

Sarah Foster

Sarah Foster is a recognized leader in advancing innovative care models and health system strategies that improve patient access to breakthrough therapies. With over 15 years of experience in neurology and Alzheimer’s disease, Sarah combines deep clinical insight with operational expertise to drive transformative solutions across diagnostics, infrastructure, and stakeholder engagement.

US5778

Register here to watch on-demand!